- Messages
- 417
- Type of diabetes
- Prediabetes
- Treatment type
- Diet only
I recently came across this informative 2015 study
https://www.sciencedirect.com/science/article/pii/S0899900714003323
which is titled "Dietary carbohydrate restriction as the first approach in diabetes management: critical review and evidence base" and says
Robust evidence/science?
The paper seems credible, but is the evidence "robust"? I suppose if someone (or an organisation) just wanted to dismiss the evidence, they could quibble with it not being from "long-term randomized controlled trials" and therefore not "robust science". However, it appears it can withstand "vigorous cross-examination" as the paper concludes on this constructive note:
I actually came across the above study since it is cited in the "Position statement" on "Low-carb diets for people with diabetes" from the charity Diabetes UK and is available here: https://www.diabetes.org.uk/profess...style/low-carb-diets-for-people-with-diabetes
Below I quote part of their "Position statement" where it references "[4]" the above study:
Notes
1 The study doesn't say "everyone with diabetes should follow a low-carbohydrate diet" but actually says "It is unlikely that one dietary strategy, any more than one kind of pharmacologic treatment will be best for all individuals."
2 There's that term "robust" again!
Saturated Fat?
The Diabetes UK Position statement says:
The study says:
Remember: "Diabetes UK continues to base recommendations on robust evidence rather than opinions"
https://www.sciencedirect.com/science/article/pii/S0899900714003323
which is titled "Dietary carbohydrate restriction as the first approach in diabetes management: critical review and evidence base" and says
Abstract
The inability of current recommendations to control the epidemic of diabetes, the specific failure of the prevailing low-fat diets to improve obesity, cardiovascular risk, or general health and the persistent reports of some serious side effects of commonly prescribed diabetic medications, in combination with the continued success of low-carbohydrate diets in the treatment of diabetes and metabolic syndrome without significant side effects, point to the need for a reappraisal of dietary guidelines. The benefits of carbohydrate restriction in diabetes are immediate and well documented. Concerns about the efficacy and safety are long term and conjectural rather than data driven. Dietary carbohydrate restriction reliably reduces high blood glucose, does not require weight loss (although is still best for weight loss), and leads to the reduction or elimination of medication. It has never shown side effects comparable with those seen in many drugs. Here we present 12 points of evidence supporting the use of low-carbohydrate diets as the first approach to treating type 2 diabetes and as the most effective adjunct to pharmacology in type 1. They represent the best-documented, least controversial results. The insistence on long-term randomized controlled trials as the only kind of data that will be accepted is without precedent in science. The seriousness of diabetes requires that we evaluate all of the evidence that is available. The 12 points are sufficiently compelling that we feel that the burden of proof rests with those who are opposed.
The inability of current recommendations to control the epidemic of diabetes, the specific failure of the prevailing low-fat diets to improve obesity, cardiovascular risk, or general health and the persistent reports of some serious side effects of commonly prescribed diabetic medications, in combination with the continued success of low-carbohydrate diets in the treatment of diabetes and metabolic syndrome without significant side effects, point to the need for a reappraisal of dietary guidelines. The benefits of carbohydrate restriction in diabetes are immediate and well documented. Concerns about the efficacy and safety are long term and conjectural rather than data driven. Dietary carbohydrate restriction reliably reduces high blood glucose, does not require weight loss (although is still best for weight loss), and leads to the reduction or elimination of medication. It has never shown side effects comparable with those seen in many drugs. Here we present 12 points of evidence supporting the use of low-carbohydrate diets as the first approach to treating type 2 diabetes and as the most effective adjunct to pharmacology in type 1. They represent the best-documented, least controversial results. The insistence on long-term randomized controlled trials as the only kind of data that will be accepted is without precedent in science. The seriousness of diabetes requires that we evaluate all of the evidence that is available. The 12 points are sufficiently compelling that we feel that the burden of proof rests with those who are opposed.
Robust evidence/science?
The paper seems credible, but is the evidence "robust"? I suppose if someone (or an organisation) just wanted to dismiss the evidence, they could quibble with it not being from "long-term randomized controlled trials" and therefore not "robust science". However, it appears it can withstand "vigorous cross-examination" as the paper concludes on this constructive note:
We would recommend that government or private health agencies hold open hearings on these issues in which researchers in carbohydrate restriction can make their case. We think that traditional features of the analysis of evidence such as vigorous cross-examination should be part of the process. We suggest that open discussion with all sides contributing will be valuable. The seriousness of diabetes suggests that a bench decree will be inappropriate.
I actually came across the above study since it is cited in the "Position statement" on "Low-carb diets for people with diabetes" from the charity Diabetes UK and is available here: https://www.diabetes.org.uk/profess...style/low-carb-diets-for-people-with-diabetes
Below I quote part of their "Position statement" where it references "[4]" the above study:
As the total amount of carbohydrate eaten has the biggest effect on the rise of blood glucose levels after eating, some experts have argued that everyone with diabetes should follow a low-carbohydrate diet [4]. However, this call for low-carb diets as a default for people with diabetes is based on opinions rather than robust science. Interpreting dietary research is not without disagreements, which is why Diabetes UK continues to base recommendations on robust evidence rather than opinions.
Notes
1 The study doesn't say "everyone with diabetes should follow a low-carbohydrate diet" but actually says "It is unlikely that one dietary strategy, any more than one kind of pharmacologic treatment will be best for all individuals."
2 There's that term "robust" again!
Saturated Fat?
The Diabetes UK Position statement says:
People who want to follow a low-carb diet should ensure their fat intake comes mainly from unsaturated sources, whilst limiting saturated fat intake.
The study says:
Point 7. Dietary total and saturated fat do not correlate with risk for cardiovascular disease
Several large and expensive clinical studies have been carried out since the so-called diet–heart hypothesis was framed in the middle of the 20th century [40], [41]. From the original Framingham study [42] to the WHI [26], as well as more than a dozen additional studies, have failed to show an association between dietary lipids and risk for cardiovascular disease (CVD). There is now a large volume of literature of both scientific papers [43], [44], [45], [46], [47] and popular books [48], [49], [50], [51] documenting the failure of attempts to support the diet–heart hypothesis. Few rebuttals have been offered [52]. The very strong recommendations from health agencies predicted that none of these trials should fail. In fact, almost all of them have failed.
Several large and expensive clinical studies have been carried out since the so-called diet–heart hypothesis was framed in the middle of the 20th century [40], [41]. From the original Framingham study [42] to the WHI [26], as well as more than a dozen additional studies, have failed to show an association between dietary lipids and risk for cardiovascular disease (CVD). There is now a large volume of literature of both scientific papers [43], [44], [45], [46], [47] and popular books [48], [49], [50], [51] documenting the failure of attempts to support the diet–heart hypothesis. Few rebuttals have been offered [52]. The very strong recommendations from health agencies predicted that none of these trials should fail. In fact, almost all of them have failed.
Remember: "Diabetes UK continues to base recommendations on robust evidence rather than opinions"